<DOC>
	<DOCNO>NCT03100474</DOCNO>
	<brief_summary>A global post approval study collect safety effectiveness data related ExAblate Neuro treatment certain disorder Essential Tremor , Parkinson 's Movement Disorders , Neuropathic Pain within thalamus and/or pallidum .</brief_summary>
	<brief_title>Global Registry : ExAblate Neuro MR Guided Focused Ultrasound ( MRgFUS ) Neurological Disorders :</brief_title>
	<detailed_description>A global , multi-center , open-label , observational registry capture safety effectiveness data related ExAblate Neuro , MRI guide focus ultrasound device design lesion tissue deep within brain use sound wave without need craniotomy . This registry include certain regional country specific approve thalamotomy pallidotomy procedure use ExAblate Neuro treatment various neurologic disorder essential tremor , Parkinson 's movement disorder , neuropathic pain . Treatment targets/indications country/region dependent base approve label within region .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<criteria>Meets label indication use per information prescribers Target accessible Focused Ultrasound per treatment planning parameter Do agree participate unlikely participate extend period time</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>tremor</keyword>
	<keyword>Parkinson 's</keyword>
	<keyword>movement</keyword>
	<keyword>neuropathic</keyword>
	<keyword>pain</keyword>
</DOC>